JP2007503204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007503204A5 JP2007503204A5 JP2006523923A JP2006523923A JP2007503204A5 JP 2007503204 A5 JP2007503204 A5 JP 2007503204A5 JP 2006523923 A JP2006523923 A JP 2006523923A JP 2006523923 A JP2006523923 A JP 2006523923A JP 2007503204 A5 JP2007503204 A5 JP 2007503204A5
- Authority
- JP
- Japan
- Prior art keywords
- embryo
- female
- stock
- cryopreserved
- pedigree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 138
- 210000001161 mammalian embryo Anatomy 0.000 claims description 114
- 241001465754 Metazoa Species 0.000 claims description 107
- 210000002257 embryonic structure Anatomy 0.000 claims description 88
- 230000002068 genetic effect Effects 0.000 claims description 75
- 230000001850 reproductive effect Effects 0.000 claims description 56
- 210000000287 oocyte Anatomy 0.000 claims description 51
- 230000013011 mating Effects 0.000 claims description 47
- 239000002243 precursor Substances 0.000 claims description 37
- 238000000338 in vitro Methods 0.000 claims description 27
- 241000283984 Rodentia Species 0.000 claims description 24
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 19
- 210000001672 ovary Anatomy 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 13
- 230000004720 fertilization Effects 0.000 claims description 11
- 210000004392 genitalia Anatomy 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000011161 development Methods 0.000 claims description 5
- 230000009027 insemination Effects 0.000 claims description 5
- 239000010902 straw Substances 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 4
- 230000035800 maturation Effects 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- 210000003141 lower extremity Anatomy 0.000 claims 4
- 238000000520 microinjection Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 74
- 241000699666 Mus <mouse, genus> Species 0.000 description 35
- 230000035772 mutation Effects 0.000 description 16
- 210000004602 germ cell Anatomy 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 12
- 208000035199 Tetraploidy Diseases 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 8
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 238000005138 cryopreservation Methods 0.000 description 6
- 210000000472 morula Anatomy 0.000 description 6
- 210000002459 blastocyst Anatomy 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 108010069112 Complement System Proteins Proteins 0.000 description 2
- 102000000989 Complement System Proteins Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 210000002593 Y chromosome Anatomy 0.000 description 2
- 102000003802 alpha-Synuclein Human genes 0.000 description 2
- 108090000185 alpha-Synuclein Proteins 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000010363 gene targeting Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010061764 Chromosomal deletion Diseases 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 244000309456 Decussocarpus nagi Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102220470475 L-seryl-tRNA(Sec) kinase_C57L_mutation Human genes 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 1
- 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 210000004952 blastocoel Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000004420 female germ cell Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 210000003794 male germ cell Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 210000000799 primary oocyte Anatomy 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 238000001963 scanning near-field photolithography Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000000801 secondary oocyte Anatomy 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49745103P | 2003-08-22 | 2003-08-22 | |
| US60/497,451 | 2003-08-22 | ||
| PCT/US2004/026003 WO2005020678A1 (en) | 2003-08-22 | 2004-08-11 | Methods for maintaining genetic stability of inbred animal strains |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012055056A Division JP2012105688A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
| JP2012055055A Division JP2012105687A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007503204A JP2007503204A (ja) | 2007-02-22 |
| JP2007503204A5 true JP2007503204A5 (enExample) | 2010-12-24 |
| JP5072359B2 JP5072359B2 (ja) | 2012-11-14 |
Family
ID=34272571
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523923A Expired - Fee Related JP5072359B2 (ja) | 2003-08-22 | 2004-08-11 | 近交系動物の遺伝的安定性を維持するための方法 |
| JP2012055055A Withdrawn JP2012105687A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
| JP2012055056A Pending JP2012105688A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012055055A Withdrawn JP2012105687A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
| JP2012055056A Pending JP2012105688A (ja) | 2003-08-22 | 2012-03-12 | 近交系動物の遺伝的安定性を維持するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7592501B2 (enExample) |
| EP (1) | EP1657977A1 (enExample) |
| JP (3) | JP5072359B2 (enExample) |
| CN (1) | CN1838880B (enExample) |
| AU (1) | AU2004268530B2 (enExample) |
| CA (1) | CA2536343C (enExample) |
| WO (1) | WO2005020678A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105210981B (zh) * | 2015-09-15 | 2018-09-28 | 中国科学院生物物理研究所 | 建立可应用于人类疾病研究的雪貂模型的方法及其应用 |
| US20190150412A1 (en) * | 2017-11-20 | 2019-05-23 | Inguran, Llc | Methods for increasing the rate of genetic progress and generating inbred lines in non-human mammals using gametes derived from embryos |
| CN110484627B (zh) * | 2019-07-30 | 2023-05-02 | 江苏集萃药康生物科技股份有限公司 | 用于监控a/j近交系小鼠遗传质量的方法、引物组及其应用 |
| CN115968833B (zh) * | 2023-02-27 | 2024-07-26 | 泉州市鑫泉农业科技有限公司 | 一种黑皮乌骨鸭的制种方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5160312A (en) | 1990-02-09 | 1992-11-03 | W. R. Grace & Co.-Conn. | Cryopreservation process for direct transfer of embryos |
| US5758763A (en) | 1995-08-17 | 1998-06-02 | Hosiden Corporation | Pantograph type keyboard switch |
| US5905042A (en) | 1996-04-01 | 1999-05-18 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Cultured inner cell mass cell lines derived from bovine or porcine embryos |
| US6949692B2 (en) | 1996-11-18 | 2005-09-27 | Wisconsin Alumni Research Foundation | Method for identifying mutants and molecules |
| AU5575899A (en) | 1998-08-20 | 2000-03-14 | Biotransplant Incorporated | Inbred mhc-homozygous miniature swine and uses thereof |
| JP2001061470A (ja) * | 1999-08-30 | 2001-03-13 | Science & Tech Agency | マウス胚性幹細胞 |
| AU2001259703A1 (en) | 2000-05-10 | 2001-11-20 | Advanced Cell Technology, Inc. | The production of agricultural animals from embryonic stem (es) cells |
| AU2001286445A1 (en) | 2000-08-10 | 2002-02-18 | Gtc Biotherapeutics, Inc. | Cryopreservation of sperm |
| NZ573760A (en) | 2006-06-12 | 2012-01-12 | Jackson Lab | Sperm cryoprotective media comprising monothioglycerol |
-
2004
- 2004-08-11 US US10/915,840 patent/US7592501B2/en not_active Expired - Lifetime
- 2004-08-11 AU AU2004268530A patent/AU2004268530B2/en not_active Ceased
- 2004-08-11 CA CA2536343A patent/CA2536343C/en not_active Expired - Lifetime
- 2004-08-11 WO PCT/US2004/026003 patent/WO2005020678A1/en not_active Ceased
- 2004-08-11 EP EP04780782A patent/EP1657977A1/en not_active Ceased
- 2004-08-11 CN CN2004800238584A patent/CN1838880B/zh not_active Expired - Lifetime
- 2004-08-11 JP JP2006523923A patent/JP5072359B2/ja not_active Expired - Fee Related
-
2009
- 2009-08-06 US US12/536,909 patent/US8110721B2/en not_active Expired - Lifetime
-
2011
- 2011-12-05 US US13/373,997 patent/US20120180146A1/en not_active Abandoned
-
2012
- 2012-03-12 JP JP2012055055A patent/JP2012105687A/ja not_active Withdrawn
- 2012-03-12 JP JP2012055056A patent/JP2012105688A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Das et al. | Role of biotechnology on animal breeding and genetic improvement | |
| US8552254B2 (en) | Methods for maintaining genetic stability of inbred animal strains | |
| Faber et al. | Agro-economic impact of cattle cloning | |
| US8110721B2 (en) | Methods for maintaining genetic stability of inbred animal strains | |
| Moore et al. | Increased male reproductive success in Ts65Dn “Down syndrome” mice | |
| JP6201265B2 (ja) | 所望の形質を有する豚の作出方法 | |
| US20050125853A1 (en) | Method for generating genetically modified animals | |
| CA2477112A1 (en) | A method for producing germline chimeric animal | |
| JP2007503204A5 (enExample) | ||
| US20150150667A1 (en) | Methods and system for managing mouse colonies | |
| Ayadi et al. | Mouse breeding and colony management | |
| Cundiff et al. | Challenges and opportunities for integrating genetically modified animals into traditional animal breeding plans | |
| Panneer et al. | Mouse Genetics and Breeding | |
| WO2005107447A2 (en) | Methods for the production of improved live stocks and disease models for therapeutic research | |
| Čechová et al. | Boosting the potential of cattle breeding using molecular biology, genetics, and bioinformatics approaches–a review | |
| Seidel Jr | Cloning, transgenesis, and genetic variance in animals | |
| Class et al. | Patent application title: METHODS FOR MAINTAINING GENETIC STABILITY OF INBRED ANIMAL STRAINS Inventors: Michael V. Wiles (Mount Desert, ME, US) Michael V. Wiles (Mount Desert, ME, US) Robert Taft (Southwest Harbor, ME, US) Robert Taft (Southwest Harbor, ME, US) Eva M. Eicher (Seal Cove, ME, US) Shannon Byers (Lamoine, ME, US) Assignees: The Jackson Laboratory | |
| WO2003072777A1 (en) | Embryonically modified animal and method of constructing the same | |
| Nagarajan | Mouse Genetics and Breeding | |
| EP1786262A1 (en) | Methods for the production of improved live stocks and disease models for therapeutic research | |
| Allan | New Technologies in Cattle Reproduction and the Correlated Acceleration of Genetic Gain | |
| Dasa et al. | Role of biotechnology on animal breeding and genetic improvement | |
| Henshall et al. | A new look at advanced reproduction technologies and their impact on livestock breeding. | |
| Garrett-Beal et al. | Managing a mouse mutant resource center... this is not your father's transgenic core | |
| Mochida et al. | G-025 Easy and quick (EQ) sperm freezing method for mouse strains |